Yescarta and Hepatitis B reactivation
Result of checking the interaction of drug Yescarta and disease Hepatitis B reactivation for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of drugs directed against B cells, such as axicabtagene ciloleucel, and tisagenlecleucel is associated with hepatitis B reactivation, some cases have resulted in fulminant hepatitis, hepatic failure, and death. Close monitoring is recommended when using these agents in patients with a history of hepatitis infection. It is recommended to screen patients for HBV, HCV, and HIV in accordance with clinical guidelines before collection of cells for manufacturing.
Generic Name: axicabtagene ciloleucel
Brand Name: Yescarta
Synonyms: n.a.